Go to deals
Private Equity | Healthcare

The MOLE Clinic Limited has been acquired by Sk:n (backed by TriSpan)

The shareholders of The MOLE Clinic Limited have sold the company to Sk:n.

The MOLE Clinic is a leading independent provider of skin cancer screening, diagnosis and treatment services to private patients and to the NHS. It screens over 30,000 patients annually using advanced diagnostic techniques from five London clinics, including on Harley Street, Oxford Circus and Moorgate, as well as via its award-winning tele-dermatology offering to GPs nationally.

Sk:n is the largest network of specialist skin care clinics in the UK and is backed by Trispan, a specialist private equity firm. This acquisition further strengthens Sk:n’s skin cancer screening offering and adds to its growing range of skin care services. As part of integrating the business into the Group, they plan to roll out The MOLE Clinic’s offering across the Sk:n clinic network nationally.

Demand for The MOLE Clinic’s services has been growing and the shareholders were looking for a strategic partner to help support their expansion. Oaklins Evelyn Partners, based in the UK, worked with the The MOLE Clinic’s shareholders to deliver a successful sale to a strategic partner that is able to expand the clinic network and help support the business through its next phase of growth.

Parties
“I found the advice and hands-on support provided by the Oaklins Evelyn Partners team to be invaluable and a significant factor in achieving a successful transaction. Their understanding of the medical and healthcare sector as well as a focus on owner-managed businesses proved vital in not just solving problems but anticipating and addressing them before they arose. I cannot recommend their team highly enough.”

Iain Mack

Founder and Managing Director, The MOLE Clinic

Talk to the deal team

Stuart Goodman

Partner
London, United Kingdom
Oaklins S&W

Related deals

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more
Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Private Equity | Business Support Services | Construction & Engineering Services

Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth

Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.

Learn more
Nuzoa has acquired Agrofauna
Private Equity | Consumer & Retail

Nuzoa has acquired Agrofauna

Nuzoa, a provider of value-added services for pets and livestock in the Iberian Peninsula, has acquired 100% of Agrofauna. This transaction reinforces Nuzoa’s presence in the Portuguese market, particularly in the northern region, marking another step toward its ambition to become the leading operator while further consolidating its brand across Iberia.

Learn more